表紙:自己免疫疾患治療薬の世界市場(2021年~2025年)
市場調査レポート
商品コード
1019502

自己免疫疾患治療薬の世界市場(2021年~2025年)

Global Autoimmune Drugs Market 2021-2025

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.08円
自己免疫疾患治療薬の世界市場(2021年~2025年)
出版日: 2021年06月11日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

自己免疫疾患治療薬の市場規模は、2021年から2025年の予測期間中にほぼ6%のCAGRで推移し、238億6,000万米ドルの成長が見込まれています。

当レポートでは、自己免疫疾患治療薬市場について、全体的な分析、市場規模と予測、動向、成長要因、課題のほか、約25社のベンダーを網羅したベンダー分析を行っています。

同市場は、手頃な価格のバイオシミラーの導入と、生物製剤の標的治療メカニズムによって促進されています。また、手頃な価格のバイオシミラーの導入は、市場の成長を後押しすると予想されます。

当レポートでは、自己免疫疾患治療薬市場を調査しており、市場の概要、市場規模、市場の見通し、顧客情勢、治療領域別・地域別の分析、さらにベンダー情勢とベンダー分析などを提供しています。

目次

エグゼクティブサマリー

市場情勢

  • 市場のエコシステム
  • バリューチェーン分析

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模:2020年
  • 市場の見通し:2020年から2025年の予測

ファイブフォース分析

  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

治療領域別市場セグメンテーション

  • 市場セグメンテーション
  • 関節リウマチ:市場規模と予測(2020年~2025年)
  • 多発性硬化症:市場規模と予測(2020年~2025年)
  • 乾癬:市場規模と予測(2020年~2025年)
  • 炎症性腸疾患:市場規模と予測(2020年~2025年)
  • その他:市場規模と予測(2020年~2025年)

顧客情勢

  • 概要

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測(2020年~2025年)
  • 欧州:市場規模と予測(2020年~2025年)
  • アジア:市場規模と予測(2020年~2025年)
  • その他の地域:市場規模と予測(2020年~2025年)
  • 主要国
  • 地域別情勢市場機会
  • 市場成長促進要因
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • 創造的破壊の状況

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA

付録

目次
Product Code: IRTNTR70662

Technavio has been monitoring the autoimmune drugs market and it is poised to grow by $ 23.86 bn during 2021-2025, progressing at a CAGR of almost 6% during the forecast period. Our report on autoimmune drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the introduction of affordable biosimilars and targeted therapeutic mechanism of biologics. In addition, introduction of affordable biosimilars is anticipated to boost the growth of the market as well.

The autoimmune drugs market analysis includes therapy area segment and geographic landscape.

Technavio's autoimmune drugs market is segmented as below:

By Therapy Area

  • Rheumatoid arthritis
  • Multiple sclerosis
  • Psoriasis
  • Inflammatory bowel disease
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the strong R&D pipeline as one of the prime reasons driving the autoimmune drugs market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on autoimmune drugs market covers the following areas:

  • Autoimmune drugs market sizing
  • Autoimmune drugs market forecast
  • Autoimmune drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoimmune drugs market vendors that include Abbott Laboratories, AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Inc., Novartis AG, Pfizer Inc., and Sanofi SA. Also, the autoimmune drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Therapy area
    • Market segments
    • Rheumatoid arthritis - Market size and forecast 2020-2025
    • Multiple sclerosis - Market size and forecast 2020-2025
    • Psoriasis - Market size and forecast 2020-2025
    • Inflammatory bowel disease - Market size and forecast 2020-2025
    • Others - Market size and forecast 2020-2025
  • Customer landscape
    • Overview
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Abbott Laboratories
    • AbbVie Inc.
    • Amgen Inc.
    • Bristol-Myers Squibb Co.
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline Plc
    • Johnson and Johnson Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Other1 - Market share 2020-2025 (%)
  • 22: Comparison by Other1
  • 23: Rheumatoid arthritis - Market size and forecast 2020-2025 ($ million)
  • 24: Rheumatoid arthritis - Year-over-year growth 2020-2025 (%)
  • 25: Multiple sclerosis - Market size and forecast 2020-2025 ($ million)
  • 26: Multiple sclerosis - Year-over-year growth 2020-2025 (%)
  • 27: Psoriasis - Market size and forecast 2020-2025 ($ million)
  • 28: Psoriasis - Year-over-year growth 2020-2025 (%)
  • 29: Inflammatory bowel disease - Market size and forecast 2020-2025 ($ million)
  • 30: Inflammatory bowel disease - Year-over-year growth 2020-2025 (%)
  • 31: Others - Market size and forecast 2020-2025 ($ million)
  • 32: Others - Year-over-year growth 2020-2025 (%)
  • 33: Market opportunity by Other1
  • 34: Customer landscape
  • 35: Market share By Geographical Landscape 2020-2025 (%)
  • 36: Geographic comparison
  • 37: North America - Market size and forecast 2020-2025 ($ million)
  • 38: North America - Year-over-year growth 2020-2025 (%)
  • 39: Europe - Market size and forecast 2020-2025 ($ million)
  • 40: Europe - Year-over-year growth 2020-2025 (%)
  • 41: Asia - Market size and forecast 2020-2025 ($ million)
  • 42: Asia - Year-over-year growth 2020-2025 (%)
  • 43: ROW - Market size and forecast 2020-2025 ($ million)
  • 44: ROW - Year-over-year growth 2020-2025 (%)
  • 45: Key leading countries
  • 46: Market opportunity By Geographical Landscape ($ million)
  • 47: Impact of drivers and challenges
  • 48: Vendor landscape
  • 49: Landscape disruption
  • 50: Industry risks
  • 51: Vendors covered
  • 52: Market positioning of vendors
  • 53: Abbott Laboratories - Overview
  • 54: Abbott Laboratories - Business segments
  • 55: Abbott Laboratories - Key offerings
  • 56: Abbott Laboratories - Key customers
  • 57: Abbott Laboratories - Segment focus
  • 58: AbbVie Inc. - Overview
  • 59: AbbVie Inc. - Product and service
  • 60: AbbVie Inc. - Key offerings
  • 61: AbbVie Inc. - Key customers
  • 62: AbbVie Inc. - Segment focus
  • 63: Amgen Inc. - Overview
  • 64: Amgen Inc. - Business segments
  • 65: Amgen Inc. - Key offerings
  • 66: Amgen Inc. - Key customers
  • 67: Amgen Inc. - Segment focus
  • 68: Bristol-Myers Squibb Co. - Overview
  • 69: Bristol-Myers Squibb Co. - Product and service
  • 70: Bristol-Myers Squibb Co. - Key offerings
  • 71: Bristol-Myers Squibb Co. - Key customers
  • 72: Bristol-Myers Squibb Co. - Segment focus
  • 73: F. Hoffmann-La Roche Ltd. - Overview
  • 74: F. Hoffmann-La Roche Ltd. - Business segments
  • 75: F. Hoffmann-La Roche Ltd. - Key offerings
  • 76: F. Hoffmann-La Roche Ltd. - Key customers
  • 77: F. Hoffmann-La Roche Ltd. - Segment focus
  • 78: GlaxoSmithKline Plc - Overview
  • 79: GlaxoSmithKline Plc - Business segments
  • 80: GlaxoSmithKline Plc - Key offerings
  • 81: GlaxoSmithKline Plc - Key customers
  • 82: GlaxoSmithKline Plc - Segment focus
  • 83: Johnson and Johnson Inc. - Overview
  • 84: Johnson and Johnson Inc. - Business segments
  • 85: Johnson and Johnson Inc. - Key offerings
  • 86: Johnson and Johnson Inc. - Key customers
  • 87: Johnson and Johnson Inc. - Segment focus
  • 88: Novartis AG - Overview
  • 89: Novartis AG - Business segments
  • 90: Novartis AG - Key offerings
  • 91: Novartis AG - Key customers
  • 92: Novartis AG - Segment focus
  • 93: Pfizer Inc. - Overview
  • 94: Pfizer Inc. - Business segments
  • 95: Pfizer Inc. - Key offerings
  • 96: Pfizer Inc. - Key customers
  • 97: Pfizer Inc. - Segment focus
  • 98: Sanofi SA - Overview
  • 99: Sanofi SA - Business segments
  • 100: Sanofi SA - Key offerings
  • 101: Sanofi SA - Key customers
  • 102: Sanofi SA - Segment focus
  • 103: Currency conversion rates for US$
  • 104: Research Methodology
  • 105: Validation techniques employed for market sizing
  • 106: Information sources
  • 107: List of abbreviations